Title

Expression of Protein Kinase Cα and the MZF-1 and Elk-1 Transcription Factors in Human Bladder Transitional Cell Carcinoma Cells

DOI

10.4077/CJP.2012.AMM121

Authors

Yeong-Chin Jou;Yung-Wei Chiu;Yieng-How Chen;Jin-Ming Hwang;Pei-Yu Chao;Jiuan-Jen Shiu;Wen-Hung Hwang;Jer-Yuh Liu;Li-Sung Hsu

Key Words

PKCα ; Elk-1 ; MZF-1 ; urinary bladder transitional cell carcinoma

PublicationName

The Chinese Journal of Physiology

Volume or Term/Year and Month of Publication

55卷2期(2012 / 04 / 01)

Page #

75 - 81

Content Language

英文

English Abstract

In a recent study on hepatocellular carcinoma (HCC), we have shown that the transcription factors Myeloid Zinc Finger-1 (MZF-1) and Ets-like-protein 1 (Elk-1) are significantly related to protein kinase C alpha (PKCα) expression. The purpose of this study was to determine the correlation of the expression of PKCαwith the expression of Elk-1 and MZF-1 in various differentiated urinary bladder transitional cell carcinoma (TCC) cell lines: 5637, BFTC905, TSGH8301, HT1376 and HT1197 cells. The malignant potential in the five TCC cell lines was examined by using cell proliferation/migration/ invasion assay and the protein and mRNA levels of PKCα, ElK-1 and MZF-1 were examined by Western blot and RT-PCR analysis. The results showed that the rate of cell proliferation in the TSGH8301 cell line was higher than that in other cell lines, while there were obvious signs of cell migration and invasion in 5637, BFTC905 and HT1376 cells, and no sign in TSGH8301 and HT1197 cells. The resulting expression levels of Elk-1 and PKCαwere the highest in 5637 cells, but the MZF-1 expression observed in all five cell lines showed no significant difference. To determine whether a correlation exists between PKCαand Elk-1, a shRNA knockout assay was performed and the results showed that the reduction of Elk-1 expression in 5637 cells did not result in the decreased PKCαexpression. Therefore, although the findings showed elevated expression of Elk-1 and PKCαin 5637 cells, the regulator of PKCαin bladder cancer cells is yet to be determined.

Topic Category 醫藥衛生 > 基礎醫學
Reference
  1. Hsieh, Y. H.,Wu, T. T.,Huang, C. Y.,Hsieh, Y. S.,Liu, J. Y.(2007).Suppression of tumorigenicity of human hepatocellular carcinoma cells by antisense oligonucleotide MZF-1.Chinese J. Physiol.,50(2),9-15.
    連結:
  2. Tsai, J.,Tsai, M.,Su, W.,Chen, Y.,Wu, T.,Hsieh, Y.,Huang, C.,Yeh, K.,Liu, J.(2005).Expression of protein kinase Cα in biopsies and surgical specimens of human hepatocellular carcinoma.Chinese J. Physiol.,48(3),139-143.
    連結:
  3. Aaltonen, V.,Koivunen, J.,Laato, M.,Peltonen, J.(2006).Heterogeneity of cellular proliferation within transitional cell carcinoma: correlation of protein kinase C alpha/betaI expression and activity.J. Histochem. Cytochem.,54(7),795-806.
  4. Ahmad, S.,Glazer, R. I.(1993).Expression of the antisense cDNA for protein kinase Cα attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells.Mol. Pharmacol.,43,858-862.
  5. Aziz, M. H.,Hafeez, B. B.,Sand, J. M.,Pierce, D. B.,Aziz, S. W.,Dreckschmidt, N. E.,Verma, A. K.(2010).Protein kinase Cε mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2).Oncogene,29(21),3100-3109.
  6. Chang, J.(2004).An economic and efficient method of RNAi vector constructions.Anal. Biochem.,334(1),199-200.
  7. De Petro, G.,Tavian, D.,Copeta, A.,Portolani, N.,Giulini, S. M.,Barlati, S.(1998).Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.Cancer Res.,58(10),2234-2239.
  8. Fournier, D. B.,Chisamore, M.,Lurain, J. R.,Rademaker, A. W.,Jordan, V. C.,Tonetti, D. A.(2001).Protein kinase Cα expression is inversely related to ER status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial cancer.Gynecol. Oncol.,81,366-372.
  9. Hsieh, Y. H.,Wu, T. T.,Huang, C. Y.,Hsieh, Y. S.,Hwang, J. M.,Liu, J. Y.(2007).p38 Mitogen-activated protein kinase pathway is involved in protein kinase Cα-regulated invasion in human hepatocellular carcinoma cells.Cancer Res.,67,4320-4327.
  10. Hsieh, Y. H.,Wu, T. T.,Tsai, J. H.,Huang, C. Y.,Hsieh, Y. S.,Liu, J. Y.(2006).PKCα expression regulated by Elk-1 and MZF-1 in human HCC cells.Biochem. Biophys. Res. Commun.,339(1),217-225.
  11. Jiang, X. H.,Tu, S. P.,Cui, J. T.,Lin, M.,Xia, H. H. X.,Wong, W. M.,Chan, A. O. O.,Yuen, M. F.,Jiang, S. H.,Lam, S. K.(2004).Antisense targeting protein kinase Cα and β1 inhibits gastric carcinogenesis.Cancer Res.,64,5787-5794.
  12. Koivunen, J.,Aaltonen, V.,Koskela, S.,Lehenkari, P.,Laato, M.,Peltonen, J.(2004).Protein kinase Cα/β inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells.Cancer Res.,64,5693-5701.
  13. Kong, C.,Zhu, Y.,Liu, D.,Yu, M.,Li, S.,Li, Z.,Sun, Z.,Liu, G.(2005).Role of protein kinase Cα in superficial bladder carcinoma recurrence.Urology,65,1228-1232.
  14. Koren, R.,Ben Meir, D.,Langzam, L.,Dekel, Y.,Konichezky, M.,Baniel, J.,Livne, P. M.,Gal, R.,Sampson, S. R.(2004).Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate.Oncol. Rep.,11(2),321-326.
  15. Lahn, M.,Kohler, G.,Sundell, K.,Su, C.,Li, S.,Paterson, B. M.,Bumol, T. F.(2004).Protein kinase Cα expression in breast and ovarian cancer.Oncology,67(1),1-10.
  16. Langzam, L.,Koren, R.,Gal, R.,Kugel, V.,Paz, A.,Farkas, A.,Sampson, S. R.(2001).Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder.Am. J. Clin. Pathol.,116(3),377-385.
  17. Leinonen, P.,Aaltonen, V.,Koskela, S.,Lehenkari, P.,Korkiamaki, T.,Peltonen, J.(2007).Impaired gap junction formation and intercellular calcium signaling in urinary bladder cancer cells can be improved by Go6976.Cell Comm. Adhes.,14(4),125-136.
  18. Liu, B.,Maher, R. J.,Hannun, Y. A.,Porter, A. T.,Honn, K. V.(1994).12 (S)-HETE enhancement of prostate tumor cell invasion: selective role of PKCα.J. Natl. Cancer Inst.,86(15),1145-1150.
  19. Mackay, H.,Twelves, C.(2007).Targeting the protein kinase C family: are we there yet?.Nat. Rev. Cancer,7,554-562.
  20. Mandil, R.,Ashkenazi, E.,Blass, M.,Kronfeld, I.,Kazimirsky, G.,Rosenthal, G.,Umansky, F.,Lorenzo, P. S.,Blumberg, P. M.,Brodie, C.(2001).Protein kinase Cα and protein kinase Cδ play opposite roles in the proliferation and apoptosis of glioma cells.Cancer Res.,61,4612-4619.
  21. Nakashima, S.(2002).Protein kinase Cα (PKCα): regulation and biological function.J. Biochem.,132(5),669-675.
  22. Newton, A. C.(1995).Protein kinase C: structure, function, and regulation.J. Biol. Chem.,270,28495-28498.
  23. Ohno, S.,Nishizuka, Y.(2002).Protein kinase C isotypes and their specific functions: prologue.J. Biochem.,132(4),509-511.
  24. Swiatkowski, S.,Seifert, H. H.,Steinhoff, C.,Prior, A.,Thievessen, I.,Schliess, F.,Schulz, W. A.(2003).Activities of MAP-kinase pathways in normal uroepithelial cells and urothelial carcinoma cell lines.Exp. Cell Res.,282(1),48-57.
  25. Varga, A.,Czifra, G.,Tallai, B.,Nemeth, T.,Kovacs, I.,Kovacs, L.,Biro, T.(2004).Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas.Eur. Urol.,46(4),462-465.
  26. Wang, X. Y.,Repasky, E.,Liu, H. T.(1999).Antisense inhibition of protein kinase Cα reverses the transformed phenotype in human lung carcinoma cells.Exp. Cell Res.,250(1),253-263.
  27. Ways, D. K.,Kukoly, C. A.,de Vente, J.,Hooker, J. L.,Bryant, W. O.,Posekany, K. J.,Fletcher, D. J.,Cook, P. P.,Parker, P. J.(1995).MCF-7 breast cancer cells transfected with protein kinase Cα exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.J. Clin. Invest.,95,1906-1915.
  28. Wu, T. T.,Hsieh, Y. H.,Hsieh, Y. S.,Liu, J. Y.(2008).Reduction of PKCα decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.J. Cell. Biochem.,103(1),9-20.
  29. Ying, T. H.,Hsieh, Y. H.,Hsieh, Y. S.,Liu, J. Y.(2008).Antisense oligonucleotide Elk-1 suppresses the tumorigenicity of human hepatocellular carcinoma cells.Cell Biol. Int.,32(2),210-216.
Times Cited
  1. 蔡隆宏(2014)。LKB1缺失促進肺腺癌腫瘤化之機制。中山醫學大學醫學研究所學位論文。2014。1-116。